Latest update:
Thursday, May 5, 2022 - 13:02
Sofia, Bulgaria, May 5, 2022 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for April 2022 the Company recorded an increase in sales of 44% compared to the same month of the previous year, incl. 60% increase in domestic sales and 38% increase in export sales as a result of erratic recovery of activity in major foreign markets.
For the four months since the beginning of the year the revenues from sales of products increase by 34%, incl. 75% increase of sales for the domestic market and 10% increase in export sales.
Use of cookies
We would like to use cookies to better understand your use of this website. This helps us improve your future experience when visiting our website. If you continue your visit on our website, we shall assume that you agree with the cookies used. Detailed information on the use of cookies on this website and how to manage or withdraw your consent at any time, can be found in our